Literature DB >> 20687471

Centrosomes, polyploidy and cancer.

Anette Duensing1, Stefan Duensing.   

Abstract

Cancer cells are frequently characterized by ploidy changes including tetra-, poly- or aneuploidy. At the same time, malignant cells often contain supernumerary centrosomes. Aneuploidy and centrosome alterations are both hallmarks of tumor aggressiveness and increase with malignant progression. It has been proposed that aneuploidy results from a sequence of events in which failed mitoses produce tetra-/polyploid cells that enter a subsequent cell division with an increased number of centrosomes and hence with an increased risk for multipolar spindle formation and chromosome missegregation. Although this model attempts to integrate several common findings in cancer cells, it has been difficult to prove. Findings that centrosome aberrations can arise in diploid cells and the uncertain proliferative potential of polyploid cells suggest that alternative routes to chromosomal instability may exist. We discuss here recent results on centrosome biogenesis and the possible link between ploidy changes, centrosome aberrations and cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20687471     DOI: 10.1007/978-1-4419-6199-0_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

Review 1.  Let's huddle to prevent a muddle: centrosome declustering as an attractive anticancer strategy.

Authors:  A Ogden; P C G Rida; R Aneja
Journal:  Cell Death Differ       Date:  2012-06-01       Impact factor: 15.828

Review 2.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Authors:  Jennifer Prescott; Ingrid M Wentzensen; Sharon A Savage; Immaculata De Vivo
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

3.  Centrosome Aberration Frequency and Disease Association in B-Acute Lymphoblastic Leukemia.

Authors:  Lily S Kerketta; Kanjaksha Ghosh; Anita Nadkarni; Manisha Madkaikar; Babu Rao Vundinti
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

4.  CAND1 promotes PLK4-mediated centriole overduplication and is frequently disrupted in prostate cancer.

Authors:  Nina Korzeniewski; Markus Hohenfellner; Stefan Duensing
Journal:  Neoplasia       Date:  2012-09       Impact factor: 5.715

5.  SCF ubiquitin ligases in the maintenance of genome stability.

Authors:  Joshua S Silverman; Jeffrey R Skaar; Michele Pagano
Journal:  Trends Biochem Sci       Date:  2011-11-16       Impact factor: 13.807

6.  Upregulation of centromere protein H is associated with progression of renal cell carcinoma.

Authors:  Xun Wu; Youcheng Lin; Liping Shi; Yi Huang; Caiyong Lai; Yongqiang Wang; Meng Zhang; Shupeng Wang; Baoli Heng; Ganshen Yu; Xinghua Du; Lu Fang; Yu Fu; Jie Chen; Zexiong Guo; Zexuan Su; Song Wu
Journal:  J Mol Histol       Date:  2015-08-07       Impact factor: 2.611

7.  An association between nuclear morphology and immunohistochemical expression of p53 and p16INK4A in lung cancer cells.

Authors:  Koji Okudela
Journal:  Med Mol Morphol       Date:  2013-09-14       Impact factor: 2.309

8.  Oocyte-targeted deletion reveals that hsp90b1 is needed for the completion of first mitosis in mouse zygotes.

Authors:  Christophe Audouard; Florent Le Masson; Colette Charry; Zihai Li; Elisabeth S Christians
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

Review 9.  The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators.

Authors:  Alessia Fabbri; Sara Travaglione; Giulia Ballan; Stefano Loizzo; Carla Fiorentini
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

10.  A screen for selective killing of cells with chromosomal instability induced by a spindle checkpoint defect.

Authors:  Zeeshan Shaukat; Heidi W S Wong; Shannon Nicolson; Robert B Saint; Stephen L Gregory
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.